Pricing Log in Create free account
Saturday 17 October 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Labcorp Holdings Inc. (LH) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a EV/Sales of 2.2×. Over the past ten years it has ranged from 1.3× (March 2020) to 2.5× (April 2015); the current reading is higher than 95% of that period. That is below the Diagnostics & Research industry median of 5.5× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.8× 2.76%
FY2024 1.8× (9.36%)
FY2023 2.0× (0.61%)
FY2022 2.0× (13.97%)
FY2021 2.3× 47.27%
FY2020 1.6× (11.79%)
FY2019 1.8× 20.31%
FY2018 1.5× (25.50%)
FY2017 2.0× 15.94%
FY2016 1.7× (6.17%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.0× 5.10%
Mar 2026 1.9× 4.00%
Dec 2025 1.8× (11.46%)
Sep 2025 2.1× 5.43%
42 more quarters

Against its own ten years

Low 1.3× High 2.5×
Ten-year median 1.9×
Current reading's percentile 99

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
MEDP Medpace Holdings, Inc. compare 6.1×
RVTY Revvity Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. compare 9.0×
IDXX IDEXX Laboratories, Inc. compare 9.8×
WAT Waters Corporation compare 10.2×
GH Guardant Health, Inc. compare 18.2×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LH